About this trial
The goal of this clinical trial is to pilot test a psychosocial-behavioral mobile health (mHealth) human immunodeficiency virus (HIV) prevention intervention in people who use drugs presenting to the emergency department (ED). The main question the study aims to answer is: is the intervention acceptable and appropriate? Participants will use the mHealth app while waiting in the ED and also at home for 90 days. Participants will be asked to complete surveys at baseline, before leaving the ED, and at 30-, 60-, and 90-day follow up visits.
Eligibility criteria
Qualifiers
At least 18 years old
No HIV positive test in electronic medical record or self-reported
Past month HIV risk behavior (condomless sex or needle sharing not protected by adherent PrEP [pre-exposure prophylaxis])
Past month use of illicit drugs (excluding marijuana)
Disqualifiers
Unable to provide informed consent
Medical or psychiatric condition that would interfere with ability to participate in study procedures
Presented to the emergency department (ED) for a psychiatric issue
Expected to be admitted to ED for more than 48 hours
Trial design
Treatments tested in this trial
- mSYNC
Treatment groups
Locations
Sponsors and collaborators
Brigham and Women's Hospital
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator